ACCESS GPO Announces Preferred Strategic Agreement for Affera Mapping and Ablation System

Got story updates? Submit your updates here. ›

ACCESS GPO, a leading group purchasing organization, has announced a preferred strategic commercial agreement to provide healthcare providers with access to the Affera Mapping and Ablation System, an advanced cardiac mapping and ablation technology. The agreement aims to make this cutting-edge medical technology more widely available to healthcare facilities across the United States.

Why it matters

The Affera system represents a significant advancement in the treatment of cardiac arrhythmias, offering improved mapping capabilities and more precise ablation procedures. By partnering with ACCESS GPO, more hospitals and clinics will be able to offer this technology to their patients, potentially improving outcomes and reducing the burden of heart rhythm disorders.

The details

The Affera Mapping and Ablation System is a comprehensive platform that combines high-resolution 3D mapping, advanced algorithms, and intuitive user interfaces to assist physicians in the diagnosis and treatment of complex cardiac arrhythmias. The agreement with ACCESS GPO will streamline the procurement process and provide favorable pricing for healthcare facilities, making it more accessible to a wider range of patients.

• The agreement was announced on March 13, 2026.